Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

IDEAYA Biosciences' Cash Balance As Of December 31, 2023 Of $632.6M, Supplemented By Net Proceeds Of $342.3M From January 2024 Atm Offerings, Expected To Fund Operations Into 2028

Author: Benzinga Newsdesk | February 20, 2024 07:03am

Posted In: IDYA